May 21, 2021 / 03:20PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Well, good morning once again, and thank you for joining us for our second virtual oncology day. I'm Yaron Werber, biotech analyst at Cowen. And it's a great pleasure to moderate the session today with Amgen. The 2 gentlemen here really need no introduction. We have David Reese, who's EVP of R&D; and Arvind Sood, VP of IR. Gentlemen, thanks so much for joining us. We really appreciate it.
Arvind Sood - Amgen Inc. - VP of IR
Good morning.
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
There's lots to talk about, especially the Lakers and the Celtics, but maybe we'll leave that for the last 2 minutes because that's going to be -- that's an ongoing battle.
Questions and Answers:
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology AnalystSo let's start first
Trustpilot
